CAN2_HUMAN - dbPTM
CAN2_HUMAN - PTM Information in dbPTM
Basic Information of Protein
UniProt ID CAN2_HUMAN
UniProt AC P17655
Protein Name Calpain-2 catalytic subunit
Gene Name CAPN2
Organism Homo sapiens (Human).
Sequence Length 700
Subcellular Localization Cytoplasm. Cell membrane. Translocates to the plasma membrane upon Ca(2+) binding.
Protein Description Calcium-regulated non-lysosomal thiol-protease which catalyzes limited proteolysis of substrates involved in cytoskeletal remodeling and signal transduction. Proteolytically cleaves MYOC at 'Arg-226'. [PubMed: 17650508 Proteolytically cleaves CPEB3 following neuronal stimulation which abolishes CPEB3 translational repressor activity, leading to translation of CPEB3 target mRNAs (By similarity]
Protein Sequence MAGIAAKLAKDREAAEGLGSHDRAIKYLNQDYEALRNECLEAGTLFQDPSFPAIPSALGFKELGPYSSKTRGIEWKRPTEICADPQFIIGGATRTDICQGALGDCWLLAAIASLTLNEEILARVVPLNQSFQENYAGIFHFQFWQYGEWVEVVVDDRLPTKDGELLFVHSAEGSEFWSALLEKAYAKINGCYEALSGGATTEGFEDFTGGIAEWYELKKPPPNLFKIIQKALQKGSLLGCSIDITSAADSEAITFQKLVKGHAYSVTGAEEVESNGSLQKLIRIRNPWGEVEWTGRWNDNCPSWNTIDPEERERLTRRHEDGEFWMSFSDFLRHYSRLEICNLTPDTLTSDTYKKWKLTKMDGNWRRGSTAGGCRNYPNTFWMNPQYLIKLEEEDEDEEDGESGCTFLVGLIQKHRRRQRKMGEDMHTIGFGIYEVPEELSGQTNIHLSKNFFLTNRARERSDTFINLREVLNRFKLPPGEYILVPSTFEPNKDGDFCIRVFSEKKADYQAVDDEIEANLEEFDISEDDIDDGFRRLFAQLAGEDAEISAFELQTILRRVLAKRQDIKSDGFSIETCKIMVDMLDSDGSGKLGLKEFYILWTKIQKYQKIYREIDVDRSGTMNSYEMRKALEEAGFKMPCQLHQVIVARFADDQLIIDFDNFVRCLVRLETLFKIFKQLDPENTGTIELDLISWLCFSVL
Overview of Protein Modification Sites with Functional and Structural Information
Experimental Post-Translational Modification Sites

* ASA = Accessible Surface Area

Locations Modification Substrate Peptides
&
Secondary Structure
ASA (%) Reference Orthologous
Protein Cluster
2Acetylation------MAGIAAKLA
------CCCHHHHHH
20.3522814378
7Acetylation-MAGIAAKLAKDREA
-CCCHHHHHHHHHHH
39.7023236377
23MethylationEGLGSHDRAIKYLNQ
HCCCCHHHHHHHHHH
32.56-
26UbiquitinationGSHDRAIKYLNQDYE
CCHHHHHHHHHHHHH
42.5821890473
32PhosphorylationIKYLNQDYEALRNEC
HHHHHHHHHHHHHHH
8.0427642862
50PhosphorylationGTLFQDPSFPAIPSA
CCCCCCCCCCCCCHH
52.7514993287
61AcetylationIPSALGFKELGPYSS
CCHHCCCHHHCCCCC
50.67156195
61UbiquitinationIPSALGFKELGPYSS
CCHHCCCHHHCCCCC
50.67-
67PhosphorylationFKELGPYSSKTRGIE
CHHHCCCCCCCCCCC
28.6129514088
68PhosphorylationKELGPYSSKTRGIEW
HHHCCCCCCCCCCCC
32.0025159151
69UbiquitinationELGPYSSKTRGIEWK
HHCCCCCCCCCCCCC
35.9821890473
76AcetylationKTRGIEWKRPTEICA
CCCCCCCCCCCCCCC
35.3926051181
82GlutathionylationWKRPTEICADPQFII
CCCCCCCCCCCCEEE
2.6022555962
82S-nitrosylationWKRPTEICADPQFII
CCCCCCCCCCCCEEE
2.602212679
182 (in isoform 2)Ubiquitination-36.17-
219UbiquitinationAEWYELKKPPPNLFK
HHHHHCCCCCCCHHH
75.32-
230UbiquitinationNLFKIIQKALQKGSL
CHHHHHHHHHHCCCC
40.43-
230MalonylationNLFKIIQKALQKGSL
CHHHHHHHHHHCCCC
40.4326320211
234UbiquitinationIIQKALQKGSLLGCS
HHHHHHHCCCCCCCE
51.85-
257UbiquitinationSEAITFQKLVKGHAY
CCCEEHHHHHCCCCE
51.56-
260AcetylationITFQKLVKGHAYSVT
EEHHHHHCCCCEECC
56.2526051181
260MalonylationITFQKLVKGHAYSVT
EEHHHHHCCCCEECC
56.2526320211
260UbiquitinationITFQKLVKGHAYSVT
EEHHHHHCCCCEECC
56.2521890473
264PhosphorylationKLVKGHAYSVTGAEE
HHHCCCCEECCCCEE
9.6728152594
265PhosphorylationLVKGHAYSVTGAEEV
HHCCCCEECCCCEEE
17.6228152594
267PhosphorylationKGHAYSVTGAEEVES
CCCCEECCCCEEECC
25.4128152594
274PhosphorylationTGAEEVESNGSLQKL
CCCEEECCCCCEEEE
52.2227251275
277PhosphorylationEEVESNGSLQKLIRI
EEECCCCCEEEEEEE
31.7027251275
280AcetylationESNGSLQKLIRIRNP
CCCCCEEEEEEEECC
51.6926051181
280MalonylationESNGSLQKLIRIRNP
CCCCCEEEEEEEECC
51.6926320211
280UbiquitinationESNGSLQKLIRIRNP
CCCCCEEEEEEEECC
51.6921906983
326SulfoxidationHEDGEFWMSFSDFLR
CCCCCEEECHHHHHH
3.3530846556
344PhosphorylationRLEICNLTPDTLTSD
CCCCCCCCCCCCCCC
12.7221406692
347PhosphorylationICNLTPDTLTSDTYK
CCCCCCCCCCCCHHH
32.8921406692
349PhosphorylationNLTPDTLTSDTYKKW
CCCCCCCCCCHHHCE
27.0121406692
350PhosphorylationLTPDTLTSDTYKKWK
CCCCCCCCCHHHCEE
30.9421406692
352PhosphorylationPDTLTSDTYKKWKLT
CCCCCCCHHHCEEEE
36.6921406692
353PhosphorylationDTLTSDTYKKWKLTK
CCCCCCHHHCEEEEE
18.6328152594
354UbiquitinationTLTSDTYKKWKLTKM
CCCCCHHHCEEEEEC
55.01-
354AcetylationTLTSDTYKKWKLTKM
CCCCCHHHCEEEEEC
55.017609103
355AcetylationLTSDTYKKWKLTKMD
CCCCHHHCEEEEECC
38.8615609665
359PhosphorylationTYKKWKLTKMDGNWR
HHHCEEEEECCCCCC
22.1621601212
360UbiquitinationYKKWKLTKMDGNWRR
HHCEEEEECCCCCCC
45.4921906983
369PhosphorylationDGNWRRGSTAGGCRN
CCCCCCCCCCCCCCC
17.1727273156
370PhosphorylationGNWRRGSTAGGCRNY
CCCCCCCCCCCCCCC
31.9527251275
377PhosphorylationTAGGCRNYPNTFWMN
CCCCCCCCCCCCEEC
4.4027251275
380PhosphorylationGCRNYPNTFWMNPQY
CCCCCCCCCEECHHH
17.7327251275
383SulfoxidationNYPNTFWMNPQYLIK
CCCCCCEECHHHEEE
4.5930846556
390SumoylationMNPQYLIKLEEEDED
ECHHHEEECCCCCCC
47.45-
390SumoylationMNPQYLIKLEEEDED
ECHHHEEECCCCCCC
47.45-
398 (in isoform 2)Ubiquitination-56.81-
403PhosphorylationEDEEDGESGCTFLVG
CCCCCCCCCHHHHHH
44.7021712546
405GlutathionylationEEDGESGCTFLVGLI
CCCCCCCHHHHHHHH
3.1922555962
406PhosphorylationEDGESGCTFLVGLIQ
CCCCCCHHHHHHHHH
24.4327251275
414AcetylationFLVGLIQKHRRRQRK
HHHHHHHHHHHHHHH
31.8926051181
414UbiquitinationFLVGLIQKHRRRQRK
HHHHHHHHHHHHHHH
31.89-
434PhosphorylationHTIGFGIYEVPEELS
CCCCCEEEECCHHHC
15.9727642862
450UbiquitinationQTNIHLSKNFFLTNR
CCCEEEECCEEECCC
65.22-
462PhosphorylationTNRARERSDTFINLR
CCCHHHHCCCEECHH
35.9329255136
464PhosphorylationRARERSDTFINLREV
CHHHHCCCEECHHHH
27.8829255136
476UbiquitinationREVLNRFKLPPGEYI
HHHHHHCCCCCCCEE
57.7721890473
568UbiquitinationLAKRQDIKSDGFSIE
HHHCCCCCCCCCEEE
51.27-
569PhosphorylationAKRQDIKSDGFSIET
HHCCCCCCCCCEEEE
43.2121712546
577S-nitrosylationDGFSIETCKIMVDML
CCCEEEEEEEEEEEE
1.502212679
580SulfoxidationSIETCKIMVDMLDSD
EEEEEEEEEEEECCC
0.9730846556
583SulfoxidationTCKIMVDMLDSDGSG
EEEEEEEEECCCCCC
2.8130846556
586PhosphorylationIMVDMLDSDGSGKLG
EEEEEECCCCCCCCC
39.65-
589PhosphorylationDMLDSDGSGKLGLKE
EEECCCCCCCCCCEE
37.4321712546
591UbiquitinationLDSDGSGKLGLKEFY
ECCCCCCCCCCEEEH
40.87-
595UbiquitinationGSGKLGLKEFYILWT
CCCCCCCEEEHHHHH
43.93-
596 (in isoform 2)Ubiquitination-49.04-
607PhosphorylationLWTKIQKYQKIYREI
HHHHHHHHHHHHHHC
9.9226074081
611PhosphorylationIQKYQKIYREIDVDR
HHHHHHHHHHCCCCC
14.8326074081
619PhosphorylationREIDVDRSGTMNSYE
HHCCCCCCCCCCHHH
33.8726074081
621PhosphorylationIDVDRSGTMNSYEMR
CCCCCCCCCCHHHHH
17.9026074081
624PhosphorylationDRSGTMNSYEMRKAL
CCCCCCCHHHHHHHH
16.2026074081
625PhosphorylationRSGTMNSYEMRKALE
CCCCCCHHHHHHHHH
14.5626074081
629UbiquitinationMNSYEMRKALEEAGF
CCHHHHHHHHHHCCC
56.89-
637AcetylationALEEAGFKMPCQLHQ
HHHHCCCCCCCEEEH
40.8026051181
637UbiquitinationALEEAGFKMPCQLHQ
HHHHCCCCCCCEEEH
40.80-
638SulfoxidationLEEAGFKMPCQLHQV
HHHCCCCCCCEEEHH
3.6130846556
674UbiquitinationVRLETLFKIFKQLDP
HHHHHHHHHHHHCCC
50.8021890473

Upstream regulatory proteins (kinases for phosphorylation sites, E3 ubiquitin ligases of ubiquitination sites, ...)
Modified Location Modified Residue Modification Type of Upstream Proteins Gene Name of Upstream Proteins UniProt AC of Upstream Proteins Sources
50SPhosphorylationKinaseMAPK1P28482
GPS
50SPhosphorylationKinaseMAPK3P27361
GPS
369SPhosphorylationKinasePRKACAP17612
GPS
369SPhosphorylationKinasePKA-FAMILY-GPS
369SPhosphorylationKinasePKA_GROUP-PhosphoELM
370TPhosphorylationKinasePRKACAP17612
GPS
370TPhosphorylationKinasePKA-FAMILY-GPS
370TPhosphorylationKinasePKA_GROUP-PhosphoELM

Functions of PTM Sites
Modified Location Modified Residue Modification Function Reference

Oops, there are no descriptions of PTM sites of CAN2_HUMAN !!

Disease-associated PTM Sites based on SAP

* Distance = the distance between SAP position and PTM sites.

Modified Location Modification Variant Position
(Distance <= 10)
Residue Change SAP Related Disease Reference

Oops, there are no SNP-PTM records of CAN2_HUMAN !!

Protein-Protein Interaction
Interacting Protein Gene Name Interaction Type PPI Reference Domain-Domain Interactions
CPNS1_HUMANCAPNS1physical
11517928
BCL2_HUMANBCL2physical
12000759
BID_HUMANBIDphysical
12000759
PTPRN_HUMANPTPRNphysical
11483505
TAU_HUMANMAPTphysical
14993287
ASNS_HUMANASNSphysical
22863883
PUR9_HUMANATICphysical
22863883
LIS1_HUMANPAFAH1B1physical
22863883
PAPS1_HUMANPAPSS1physical
22863883
PLPHP_HUMANPROSCphysical
22863883
PTMA_HUMANPTMAphysical
22863883
RUXE_HUMANSNRPEphysical
22863883
TBB2A_HUMANTUBB2Aphysical
22863883
EFTU_HUMANTUFMphysical
22863883
UBXN1_HUMANUBXN1physical
22863883
XPO1_HUMANXPO1physical
22863883
1433E_HUMANYWHAEphysical
22863883
UBC9_HUMANUBE2Iphysical
23395904
ATG5_HUMANATG5physical
16998475
ATX3_HUMANATXN3physical
27731380

Drug and Disease Associations
Kegg Disease
There are no disease associations of PTM sites.
OMIM Disease
There are no disease associations of PTM sites.
Kegg Drug
There are no disease associations of PTM sites.
DrugBank
There are no disease associations of PTM sites.
Regulatory Network of CAN2_HUMAN

loading...

Related Literatures of Post-Translational Modification

TOP